Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s).
D049148:Aminoacylation; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism* / Q000473:pathology; D002474:Cell-Free System; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D003956:Dialysis; D004305:Dose-Response Relationship, Drug; D004686:Encephalomyocarditis virus; D007372:Interferons / Q000494:pharmacology*; D007700:Kinetics; D007739:L Cells; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D014176:Protein Biosynthesis / Q000187:drug effects; D012333:RNA, Messenger / Q000494:pharmacology*; D012367:RNA, Viral / Q000494:pharmacology*; D012087:Reoviridae; D012270:Ribosomes / Q000187:drug effects / Q000378:metabolism; D013056:Spectrophotometry, Ultraviolet; D013997:Time Factors; D014316:Tritium; D014633:Valine
D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012367:RNA, Viral; D014316:Tritium; D007372:Interferons; D014633:Valine